INTERTRYP has been designated WHO Collaborating Centre (WHOCC) for "research on host-vector-parasite interactions to support the surveillance, control and elimination of Human African Trypanosomiasis" (Reference FRA-137, supervisors Vincent Jamonneau and Philippe Solano) for a period of 4 years from 30 April 2019.
What is a WHO Collaborating Center?
WHO Collaborating Centers are institutions, research institutes, departments of universities or academic institutes that are designated by the Director-General of WHO to carry out activities in support of the Organization's programs. There are currently more than 700 of them in over 80 Member States working with WHO in areas as diverse as nursing, occupational health, communicable diseases, nutrition, mental health, chronic diseases and health technologies.
To find out more about the WHO Collaborating Centers: https://www.who.int/fr/about/who-we-are/structure/collaborating-centres
In agreement with the WHO HAT program team, the actions of INTERTRYP CCOMS consist in providing scientific and technical support to WHO in HAT control activities with a view to its elimination, by optimising strategies and tools for medical and vector control and by participating in training. While these actions may concern all countries affected by RBT at the request of WHO, most will be carried out in countries involved in INTERTRYP research projects (Côte d'Ivoire, Guinea, Democratic Republic of Congo and Chad). They will be conducted by INTERTRYP (activity leaders: Philippe Solano, Vincent Jamonneau, Fabrice Courtin, Bruno Bucheton, Jean-Mathieu Bart and Veerle Lejon) and its main African partners: the International Livestock Research and Development Centre in the Subhumid Zone of Bobo Dioulasso, Burkina Faso (local manager Jacques Kaboré), the Pierre Richet Institute in Bouaké, Côte d'Ivoire (local manager Dramane Kaba) and the National HAT Control Programme in Conakry, Guinea (local manager Mamadou Camara).

In addition to the designation as WHOCC, INTERTRYP's expertise is also recognized by WHO through the appointment of several members of the Unit to expert committees:

Veerle Lejon, Philippe Solano and Vincent Jamonneau are WHO experts for HAT.

Veerle Lejon and Vincent Jamonneau are members of the WHO HAT elimination technical advisory group (HAT-e-TAG).

Philippe Solano is an advisor for HAT-e-TAG.

Bruno Bucheton is a member of the Integration of new tools into national and global policies.

Veerle Lejon is a member of the Neglected Tropical Diseases Diagnostics Technical Advisory Group (NTD-d-TAG) and its subgroup for HAT.